| Patent | Date |
|---|
Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System And/Or Lysosomal Storage Disorders
App 20220306568 - Boyd; Robert | 2022-09-29 |
Method for selection of high M6P recombinant proteins
Grant 11,441,138 - Do , et al. September 13, 2 | 2022-09-13 |
Methods of treating Fabry patients having renal impairment
Grant 11,426,396 - Castelli , et al. August 30, 2 | 2022-08-30 |
Methods of treating Fabry patients having renal impairment
Grant 11,389,437 - Castelli , et al. July 19, 2 | 2022-07-19 |
Methods of treating fabry patients having renal impairment
Grant 11,389,436 - Castelli , et al. July 19, 2 | 2022-07-19 |
Methods of treating Fabry patients having renal impairment
Grant 11,376,244 - Castelli , et al. July 5, 2 | 2022-07-05 |
Compositions Useful For Treatment Of Pompe Disease
App 20220193261 - Wilson; James M. ; et al. | 2022-06-23 |
Highly Purified Batches Of Pharmaceutical Grade 1-deoxygalactonojirimycin Compounds
App 20220194899 - Sheth; Kamlesh ; et al. | 2022-06-23 |
Highly Purified Batches Of Pharmaceutical Grade Migalastat And Methods Of Producing The Same
App 20220185776 - Sheth; Kamlesh ; et al. | 2022-06-16 |
Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders
Grant 11,358,926 - Boyd June 14, 2 | 2022-06-14 |
Methods of treating Fabry patients having renal impairment
Grant 11,357,762 - Castelli , et al. June 14, 2 | 2022-06-14 |
Methods of treating fabry patients having renal impairment
Grant 11,357,763 - Castelli , et al. June 14, 2 | 2022-06-14 |
Methods of treating Fabry patients having renal impairment
Grant 11,357,761 - Castelli , et al. June 14, 2 | 2022-06-14 |
Methods of treating Fabry patients having renal impairment
Grant 11,357,764 - Castelli , et al. June 14, 2 | 2022-06-14 |
Methods of treating Fabry patients having renal impairment
Grant 11,357,765 - Castelli , et al. June 14, 2 | 2022-06-14 |
Recombinant .alpha.-galactosidase A for treatment of Fabry disease
Grant 11,357,834 - Gotschall June 14, 2 | 2022-06-14 |
Use of migalastat for treating Fabry disease in pregnant patients
Grant 11,357,784 - Barth June 14, 2 | 2022-06-14 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220168290 - Castelli; Jeff ; et al. | 2022-06-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220168292 - Castelli; Jeff ; et al. | 2022-06-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220168291 - Castelli; Jeff ; et al. | 2022-06-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220168288 - Castelli; Jeff ; et al. | 2022-06-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220168287 - Castelli; Jeff ; et al. | 2022-06-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220168289 - Castelli; Jeff ; et al. | 2022-06-02 |
Highly Potent Acid Alpha-glucosidase With Enhanced Carbohydrates
App 20220162578 - GOTSCHALL; Russell ; et al. | 2022-05-26 |
Methods for Treatment of Fabry Disease
App 20220160690 - Lockhart; David J. ; et al. | 2022-05-26 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220160691 - Castelli; Jeff ; et al. | 2022-05-26 |
Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene
App 20220142998 - Benjamin; Elfrida | 2022-05-12 |
Methods of treating Fabry patients having renal impairment
Grant 11,304,940 - Castelli , et al. April 19, 2 | 2022-04-19 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20220105079 - Castelli; Jeff ; et al. | 2022-04-07 |
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry Disease
App 20220087993 - Skuban; Nina ; et al. | 2022-03-24 |
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
Grant 11,278,599 - Valenzano , et al. March 22, 2 | 2022-03-22 |
Augmented acid alpha-glucosidase for the treatment of Pompe disease
Grant 11,278,601 - Do , et al. March 22, 2 | 2022-03-22 |
Methods of treating Fabry patients having renal impairment
Grant 11,278,539 - Castelli , et al. March 22, 2 | 2022-03-22 |
Methods of treating Fabry patients having renal impairment
Grant 11,278,536 - Castelli , et al. March 22, 2 | 2022-03-22 |
Methods of treating Fabry patients having renal impairment
Grant 11,278,537 - Castelli , et al. March 22, 2 | 2022-03-22 |
Methods of treating Fabry patients having renal impairment
Grant 11,278,540 - Castelli , et al. March 22, 2 | 2022-03-22 |
Methods of treating Fabry patients having renal impairment
Grant 11,278,538 - Castelli , et al. March 22, 2 | 2022-03-22 |
Methods for treatment of Fabry disease
Grant 11,241,422 - Lockhart , et al. February 8, 2 | 2022-02-08 |
Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
App 20220031681 - Castelli; Jeff ; et al. | 2022-02-03 |
Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
Grant 11,234,972 - Benjamin February 1, 2 | 2022-02-01 |
Disulfide Bond Stabilized Polypeptide Compositions And Methods Of Use
App 20220023443 - Do; Hung ; et al. | 2022-01-27 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210393602 - Castelli; Jeff ; et al. | 2021-12-23 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210393603 - Castelli; Jeff ; et al. | 2021-12-23 |
Recombinant Human Acid Alpha-glucosidase
App 20210393747 - DO; Hung ; et al. | 2021-12-23 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210386723 - Castelli; Jeff ; et al. | 2021-12-16 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210379037 - Castelli; Jeff ; et al. | 2021-12-09 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210379036 - Castelli; Jeff ; et al. | 2021-12-09 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210379035 - Castelli; Jeff ; et al. | 2021-12-09 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210379034 - Castelli; Jeff ; et al. | 2021-12-09 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210361633 - Castelli; Jeff ; et al. | 2021-11-25 |
Methods of Treating Fabry Disease in Patients Having a Mutation in the GLA Gene
App 20210315875 - Benjamin; Elfrida | 2021-10-14 |
TATk-CDKL5 Fusion Proteins, Compositions, Formulations, and Use Thereof
App 20210268072 - Ciani; Elisabetta ; et al. | 2021-09-02 |
Augmented Acid Alpha-glucosidase For The Treatment Of Pompe Disease
App 20210268074 - DO; Hung V. ; et al. | 2021-09-02 |
Highly Potent Acid Alpha-glucosidase With Enhanced Carbohydrates
App 20210261935 - Gotschall; Russell ; et al. | 2021-08-26 |
Disulfide bond stabilized polypeptide compositions and methods of use
Grant 11,097,015 - Do , et al. August 24, 2 | 2021-08-24 |
Methods Of Treating Fabry Disease
App 20210251972 - Skuban; Nina | 2021-08-19 |
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
App 20210251971 - Benjamin; Elfrida ; et al. | 2021-08-19 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210220344 - Castelli; Jeff ; et al. | 2021-07-22 |
Method to predict response to pharmacological chaperone treatment of diseases
Grant RE48,608 - Benjamin , et al. June 29, 2 | 2021-06-29 |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
Grant 11,033,538 - Castelli , et al. June 15, 2 | 2021-06-15 |
Gene Therapy Constructs And Methods Of Use
App 20210162075 - Do; Hung ; et al. | 2021-06-03 |
Highly potent acid alpha-glucosidase with enhanced carbohydrates
Grant 10,961,522 - Gotschall , et al. March 30, 2 | 2021-03-30 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210085661 - Castelli; Jeff ; et al. | 2021-03-25 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210085660 - Castelli; Jeff ; et al. | 2021-03-25 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210069161 - Castelli; Jeff ; et al. | 2021-03-11 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210069162 - Castelli; Jeff ; et al. | 2021-03-11 |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
Grant 10,925,866 - Castelli , et al. February 23, 2 | 2021-02-23 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210038582 - Castelli; Jeff ; et al. | 2021-02-11 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210038583 - Castelli; Jeff ; et al. | 2021-02-11 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210038581 - Castelli; Jeff ; et al. | 2021-02-11 |
Treatment Of Patients With Classic Fabry Disease
App 20210038579 - Barth; Jay ; et al. | 2021-02-11 |
Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene
App 20210038625 - Benjamin; Elfrida ; et al. | 2021-02-11 |
Use Of Migalastat For Treating Fabry Disease In Pregnant Patients
App 20210038624 - Barth; Jay | 2021-02-11 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20210030730 - Castelli; Jeff ; et al. | 2021-02-04 |
Methods of treating Fabry patients having renal impairment
Grant 10,874,657 - Castelli , et al. December 29, 2 | 2020-12-29 |
Gene therapy constructs and methods of use
Grant 10,874,750 - Do , et al. December 29, 2 | 2020-12-29 |
Methods of treating Fabry patients having renal impairment
Grant 10,874,656 - Castelli , et al. December 29, 2 | 2020-12-29 |
Methods of treating fabry patients having renal impairment
Grant 10,874,655 - Castelli , et al. December 29, 2 | 2020-12-29 |
Methods of treating Fabry patients having renal impairment
Grant 10,857,141 - Castelli , et al. December 8, 2 | 2020-12-08 |
Augmented acid alpha-glucosidase for the treatment of Pompe disease
Grant 10,857,212 - Do , et al. December 8, 2 | 2020-12-08 |
Methods of treating Fabry patients having renal impairment
Grant 10,857,142 - Castelli , et al. December 8, 2 | 2020-12-08 |
Methods of treating Fabry patients having renal impairment
Grant 10,849,889 - Castelli , et al. December 1, 2 | 2020-12-01 |
Methods of treating Fabry patients having renal impairment
Grant 10,849,890 - Castelli , et al. December 1, 2 | 2020-12-01 |
Method to predict response to pharmacological chaperone treatment of diseases
Grant 10,813,921 - Benjamin , et al. October 27, 2 | 2020-10-27 |
Chemical crosslinkers
Grant 10,814,008 - Do October 27, 2 | 2020-10-27 |
Methods of treating fabry patients having renal impairment
Grant 10,806,727 - Castelli , et al. October 20, 2 | 2020-10-20 |
Methods of treating Fabry patients having renal impairment
Grant 10,799,491 - Castelli , et al. October 13, 2 | 2020-10-13 |
Compounds and methods for the treatment of Alzheimer's disease and/or cerebral amyloid angiopathy
Grant 10,793,583 - Boyd October 6, 2 | 2020-10-06 |
Methods of treating Fabry patients having renal impairment
Grant 10,792,278 - Castelli , et al. October 6, 2 | 2020-10-06 |
Methods of treating Fabry patients having renal impairment
Grant 10,792,279 - Castelli , et al. October 6, 2 | 2020-10-06 |
Cdkl5 Expression Variants And Cdkl5 Fusion Proteins
App 20200299654 - Clark; Sean | 2020-09-24 |
Dosing Regimens For The Treatment Of Fabry Disease
App 20200268890 - Greene; Douglas Stuart ; et al. | 2020-08-27 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200222378 - Castelli; Jeff ; et al. | 2020-07-16 |
Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease
App 20200222377 - Castelli; Jeff ; et al. | 2020-07-16 |
Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene
App 20200215043 - Benjamin; Elfrida | 2020-07-09 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206204 - CASTELLI; JEFF ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206203 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206202 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206208 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206205 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206210 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206206 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206209 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200206207 - Castelli; Jeff ; et al. | 2020-07-02 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20200188375 - Castelli; Jeff ; et al. | 2020-06-18 |
High Concentration Alpha-glucosidase Compositions For The Treatment Of Pompe Disease
App 20200188494 - Valenzano; Kenneth ; et al. | 2020-06-18 |
Formulations Comprising Recombinant Acid Alpha-glucosidase
App 20200171133 - Char; Hing ; et al. | 2020-06-04 |
Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
Grant 10,660,972 - Do | 2020-05-26 |
Disulfide Bond Stabilized Polypeptide Compositions And Methods Of Use
App 20200147241 - DO; Hung ; et al. | 2020-05-14 |
Drug package
Grant D877,625 - LoPrete , et al. | 2020-03-10 |
Novel Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System And/Or Lysosomal Storage
App 20200055810 - BOYD; Robert | 2020-02-20 |
Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
Grant 10,537,564 - Benjamin Ja | 2020-01-21 |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
Grant 10,525,045 - Castelli , et al. J | 2020-01-07 |
Methods for Treatment of Fabry Disease
App 20190388409 - Lockhart; David J. ; et al. | 2019-12-26 |
Formulations comprising recombinant acid alpha-glucosidase
Grant 10,512,676 - Char , et al. Dec | 2019-12-24 |
High concentration alpha-glucosidase compositions for the treatment of pompe disease
Grant 10,512,677 - Valenzano , et al. Dec | 2019-12-24 |
Method For Selection Of High M6p Recombinant Proteins
App 20190382742 - Do; Hung V. ; et al. | 2019-12-19 |
Recombinant Alpha-Galactosidase A For Treatment Of Fabry Disease
App 20190358302 - GOTSCHALL; Russell | 2019-11-28 |
Drug package
Grant D867,162 - LoPrete , et al. Nov | 2019-11-19 |
Gene Therapy Constructs And Methods Of Use
App 20190343968 - DO; Hung ; et al. | 2019-11-14 |
Methods of treating Fabry patients having renal impairment
Grant 10,471,053 - Castelli , et al. Nov | 2019-11-12 |
Compositions for preventing and/or treating degenerative disorders of the central nervous system
Grant 10,421,724 - Boyd , et al. Sept | 2019-09-24 |
Highly Potent Acid Alpha-glucosidase With Enhanced Carbohydrates
App 20190276812 - Gotschall; Russell ; et al. | 2019-09-12 |
Methods for treatment of fabry disease
Grant 10,406,143 - Lockhart , et al. Sept | 2019-09-10 |
Methods for treatment of Fabry disease
Grant 10,383,864 - Lockhart , et al. A | 2019-08-20 |
.alpha.-galactosidase A and 1-deoxygalactonojirimycin co-formulation
Grant 10,357,548 - Khanna , et al. July 23, 2 | 2019-07-23 |
Treatment Of Fabry Disease In Ert-na Ve And Ert-experienced Patients
App 20190183869 - Castelli; Jeff | 2019-06-20 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20190175570 - Castelli; Jeff ; et al. | 2019-06-13 |
Novel Compounds And Methods For The Treatment Of Alzheimer?s Disease And/Or Cerebral Amyloid Angiopathy
App 20190135832 - Boyd; Robert | 2019-05-09 |
Methods of treating fabry patients having renal impairment
Grant 10,251,873 - Castelli , et al. | 2019-04-09 |
Drug package
Grant D843,850 - LoPrete , et al. | 2019-03-26 |
Method for selection of high M6P recombinant proteins
Grant 10,227,577 - Do , et al. | 2019-03-12 |
Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
Grant 10,224,333 - Boyd , et al. | 2019-03-05 |
Highly potent acid alpha-glucosidase with enhanced carbohydrates
Grant 10,208,299 - Gotschall , et al. Feb | 2019-02-19 |
Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
Grant 10,179,128 - Clark Ja | 2019-01-15 |
Compounds and methods for the treatment of Alzheimer's disease and/or cerebral amyloid angiopathy
Grant 10,174,054 - Boyd J | 2019-01-08 |
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
App 20190000818 - Benjamin; Elfrida ; et al. | 2019-01-03 |
Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene
App 20190000819 - Benjamin; Elfrida | 2019-01-03 |
High Concentration Alpha-glucosidase Compositions For The Treatment Of Pompe Disease
App 20180360928 - Valenzano; Kenneth ; et al. | 2018-12-20 |
Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
App 20180360813 - Castelli; Jeff ; et al. | 2018-12-20 |
Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
App 20180360812 - Castelli; Jeff ; et al. | 2018-12-20 |
Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
App 20180360814 - Castelli; Jeff ; et al. | 2018-12-20 |
Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease
Grant 10,155,027 - Khanna , et al. Dec | 2018-12-18 |
Methods Of Treating Fabry Patients Having Renal Impairment
App 20180344712 - Castelli; Jeff | 2018-12-06 |
Methods for Treatment of Fabry Disease
App 20180325881 - Lockhart; David J. ; et al. | 2018-11-15 |
Stable parenteral DNJ compositions
Grant 10,117,830 - Char , et al. November 6, 2 | 2018-11-06 |
Novel Compounds And Methods For The Treatment Of Alzheimer's Disease And/Or Cerebral Amyloid Angiopathy
App 20180291037 - Boyd; Robert | 2018-10-11 |
Novel Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System
App 20180273474 - Boyd; Robert ; et al. | 2018-09-27 |
Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
Grant 10,076,514 - Benjamin September 18, 2 | 2018-09-18 |
Methods for Treatment of Fabry Disease
App 20180250279 - Lockhart; David J. ; et al. | 2018-09-06 |
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase
Grant 10,064,851 - Wustman September 4, 2 | 2018-09-04 |
Augmented Acid Alpha-glucosidase For The Treatment Of Pompe Disease
App 20180228877 - Do; Hung V. ; et al. | 2018-08-16 |
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
Grant 10,046,033 - Valenzano , et al. August 14, 2 | 2018-08-14 |
Method For The Treatment Of Pompe Disease Using 1-deoxynojirimycin Derivatives
App 20180221357 - MUGRAGE; Benjamin ; et al. | 2018-08-09 |
Compositions for preventing and/or treating lysosomal storage disorders
Grant 10,035,766 - Boyd , et al. July 31, 2 | 2018-07-31 |
Chemical Crosslinkers
App 20180185503 - DO; Hung | 2018-07-05 |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
Grant 9,999,618 - Castelli , et al. June 19, 2 | 2018-06-19 |
Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy
Grant 9,994,589 - Boyd June 12, 2 | 2018-06-12 |
Dosing Regimens For The Treatment Of Fabry Disease
App 20180153999 - Greene; Douglas Stuart ; et al. | 2018-06-07 |
Methods for treatment of Fabry disease
Grant 9,987,263 - Lockhart , et al. June 5, 2 | 2018-06-05 |
Treatment of CNS Disorders Associated with Mutations in Genes Encoding Lysosomal Enzymes
App 20180133206 - Wustman; Brandon Alan | 2018-05-17 |
Pharmacological chaperones for treating obesity
Grant 9,937,165 - Fan , et al. April 10, 2 | 2018-04-10 |
Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases
Grant 9,931,353 - Wustman , et al. April 3, 2 | 2018-04-03 |
Stable Parenteral DNJ Compositions
App 20180078497 - Char; Hing ; et al. | 2018-03-22 |
Chemical crosslinkers
Grant 9,889,203 - Do February 13, 2 | 2018-02-13 |
Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin
Grant 9,867,862 - Sjoberg , et al. January 16, 2 | 2018-01-16 |
Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System
App 20170365609 - Boyd; Robert ; et al. | 2017-12-21 |
Alpha-Galactosidase A And 1-Deoxygalactonojirimycin Co-Formulation
App 20170360901 - Khanna; Richie ; et al. | 2017-12-21 |
Stable parenteral DNJ compositions
Grant 9,827,189 - Char , et al. November 28, 2 | 2017-11-28 |
Formulations Comprising Recombinant Acid Alpha-Glucosidase
App 20170333534 - Char; Hing ; et al. | 2017-11-23 |
Method for Selection of High M6P Recombinant Proteins
App 20170335301 - Do; Hung V. ; et al. | 2017-11-23 |
Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
Grant 9,821,038 - Do November 21, 2 | 2017-11-21 |
Methods For Coupling Targeting Peptides Onto Recombinant Lysosomal Enzymes For Improved Treatments Of Lysosomal Storage Diseases
App 20170319710 - DO; HUNG | 2017-11-09 |
Highly Potent Acid Alpha-Glucosidase With Enhanced Carbohydrates
App 20170298335 - Gotschall; Russell ; et al. | 2017-10-19 |
Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene
App 20170273959 - Benjamin; Elfrida | 2017-09-28 |
Dosing Regimens for Treating And/Or Preventing Cerebral Amyloidoses
App 20170273996 - Wustman; Brandon Alan | 2017-09-28 |
Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
Grant 9,750,733 - Boyd , et al. September 5, 2 | 2017-09-05 |
Alpha-Galactosidase A And 1-Deoxygalactonojirimycin Co-Formulation For The Treatment of Fabry Disease
App 20170209548 - Khanna; Richie ; et al. | 2017-07-27 |
Sugar Derivatives Comprising Sulfur-Containing Moieties And Methods Of Making Same And Methods Of Using The Same For The Treatment Of MPS IIIC
App 20170190665 - Boyd; Robert ; et al. | 2017-07-06 |
Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe Disease
App 20170189497 - Do; Hung V. ; et al. | 2017-07-06 |
.alpha.-galactosidase A and 1-deoxygalactonojirimycin co-formulation
Grant 9,694,056 - Khanna , et al. July 4, 2 | 2017-07-04 |
Compounds And Methods For The Treatment Of Alzheimer's Disease And/Or Cerebral Amyloid Angiopathy
App 20170166588 - Boyd; Robert | 2017-06-15 |
Dosing regimens for treating and/or preventing cerebral amyloidoses
Grant 9,675,627 - Wustman June 13, 2 | 2017-06-13 |
Variant, Recombinant Beta-Glucocerebrosidase Proteins With Increased Stability And Increased Retained Catalytic Activity
App 20170157220 - Do; Hung V. | 2017-06-08 |
Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC
Grant 9,598,438 - Boyd , et al. March 21, 2 | 2017-03-21 |
Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes
Grant 9,597,324 - Wustman March 21, 2 | 2017-03-21 |
High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease
App 20170056483 - Valenzano; Kenneth ; et al. | 2017-03-02 |
Regimens For Treating And Preventing Lysosomal Disorders And Degenerative Disorders Of The Central Nervous System
App 20170056384 - Clark; Sean | 2017-03-02 |
New Method for Preparing Isofagomine and Its Derivatives
App 20170044102 - Rybczynski; Philip J. ; et al. | 2017-02-16 |
Methods for Treatment of Fabry Disease
App 20170042868 - Lockhart; David J. ; et al. | 2017-02-16 |
Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
Grant 9,566,316 - Do February 14, 2 | 2017-02-14 |
Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase
App 20170027919 - Wustman; Brandon Alan | 2017-02-02 |
Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System
App 20170020853 - Boyd; Robert ; et al. | 2017-01-26 |
Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
Grant 9,545,450 - Do January 17, 2 | 2017-01-17 |
Method to predict response to pharmacological chaperone treatment of diseases
Grant 9,545,397 - Benjamin , et al. January 17, 2 | 2017-01-17 |
Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
App 20160324839 - Castelli; Jeff ; et al. | 2016-11-10 |
Novel Compositions For Preventing And/or Treating Degenerative Disorders Of The Central Nervous System
App 20160326114 - Boyd; Robert ; et al. | 2016-11-10 |
Method for preparing isofagomine and its derivatives
Grant 9,481,700 - Rybczynski , et al. November 1, 2 | 2016-11-01 |
Methods for treatment of Fabry disease
Grant 9,480,682 - Lockhart , et al. November 1, 2 | 2016-11-01 |
Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
Grant 9,464,050 - Boyd , et al. October 11, 2 | 2016-10-11 |
Pharmacological Chaperones for Treating Obesity
App 20160287581 - Fan; Jian-Qiang ; et al. | 2016-10-06 |
Compositions for preventing and/or treating degenerative disorders of the central nervous system
Grant 9,409,862 - Boyd , et al. August 9, 2 | 2016-08-09 |
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase
Grant 9,402,837 - Wustman August 2, 2 | 2016-08-02 |
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
Grant 9,404,100 - Valenzano , et al. August 2, 2 | 2016-08-02 |
Pharmacological chaperones for treating obesity
Grant 9,381,194 - Fan , et al. July 5, 2 | 2016-07-05 |
Variant, Recombinant Beta-Glucocerebrosidase Proteins With Increased Stability And Increased Retained Catalytic Activity
App 20160184408 - Do; Hung V. | 2016-06-30 |
Chemical Crosslinkers
App 20160129126 - DO; Hung | 2016-05-12 |
High concentration .alpha.-glucosidase compositions for the treatment of Pompe disease
Grant 9,303,249 - Valenzano , et al. April 5, 2 | 2016-04-05 |
Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
Grant 9,279,007 - Do March 8, 2 | 2016-03-08 |
Method for the Treatment of Pompe Disease Using 1-Deoxynojirimycin Derivatives
App 20160051528 - Mugrage; Benjamin ; et al. | 2016-02-25 |
Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
Grant 9,254,313 - Do February 9, 2 | 2016-02-09 |
Dosing Regimens for Treating And/Or Preventing Cerebral Amyloidoses
App 20160008383 - Wustman; Brandon Alan | 2016-01-14 |
Method for Treating Cerebral Amyloid Angiopathy Using Pharmacological Chaperones to Increase the Activity of Gangliosidases
App 20150374733 - Wustman; Brandon Alan ; et al. | 2015-12-31 |
Stable Parenteral Dnj Compositions
App 20150352042 - Char; Hing ; et al. | 2015-12-10 |
Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones
App 20150352093 - Lockhart; David ; et al. | 2015-12-10 |
Utilization of pharmacological chaperones to improve manufacturing and purification of biologics
Grant 9,206,457 - Do December 8, 2 | 2015-12-08 |
Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
Grant 9,181,184 - Mugrage , et al. November 10, 2 | 2015-11-10 |
Compounds And Methods For Treating Or Preventing Disease Conditions Associated With Alpha-1-antirypsin
App 20150265671 - Sjoberg; Eric Richard ; et al. | 2015-09-24 |
Methods for Treatment of Fabry Disease
App 20150238474 - Lockhart; David ; et al. | 2015-08-27 |
Sugar Derivatives Comprising Sulfur-Containing Moieties And Methods Of Making Same and Methods of Using the Same for the Treatment of MPS IIIC
App 20150225420 - Boyd; Robert ; et al. | 2015-08-13 |
Variant, Recombinant Beta-Glucocerebrosidase Proteins With Increased Stability And Increased Retained Catalytic Activity
App 20150216950 - Do; Hung V. | 2015-08-06 |
Method to predict response to pharmacological chaperone treatment of diseases
Grant 9,095,584 - Benjamin , et al. August 4, 2 | 2015-08-04 |
Alpha-galactosidase A And 1-deoxygalactonojirimycin Co-formulation
App 20150174214 - Khanna; Richie ; et al. | 2015-06-25 |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
Grant 9,056,101 - Lockhart , et al. June 16, 2 | 2015-06-16 |
Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases
Grant 9,044,437 - Wustman , et al. June 2, 2 | 2015-06-02 |
Treatment of CNS Disorders Associated with Mutations in Genes Encoding Lysosomal Enzymes
App 20150133496 - Wustman; Brandon Alan | 2015-05-14 |
Methods for treatment of Fabry disease
Grant 9,000,011 - Lockhart , et al. April 7, 2 | 2015-04-07 |
Compounds and methods for treating or preventing disease conditions associated with .alpha.-1-antitrypsin
Grant 8,993,525 - Sjoberg , et al. March 31, 2 | 2015-03-31 |
Dosing Regimens For The Treatment Of Pompe Disease
App 20150086530 - Greene; Douglas Stuart ; et al. | 2015-03-26 |
Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
Grant 8,962,564 - Do February 24, 2 | 2015-02-24 |
Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System
App 20150050263 - Boyd; Robert ; et al. | 2015-02-19 |
High Concentration Alpha-Glucosidase Compositions for the Treatment of Pompe Disease
App 20150044194 - Valenzano; Kenneth Joseph ; et al. | 2015-02-12 |
Methods for preventing and/or treating lysosomal storage disorders
Grant 8,940,766 - Boyd , et al. January 27, 2 | 2015-01-27 |
Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase
App 20150025109 - Wustman; Brandon Alan | 2015-01-22 |
Dosing Regimens For The Treatment Of Fabry Disease
App 20140219986 - Greene; Douglas Stuart ; et al. | 2014-08-07 |
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
App 20140206721 - Benjamin; Elfrida ; et al. | 2014-07-24 |
High Concentration Alpha-Glucosidase Compositions for the Treatment of Pompe Disease
App 20140193390 - Valenzano; Kenneth ; et al. | 2014-07-10 |
Novel Compositions for Preventing and/or Treating Lysosomal Storage Disorders
App 20140086896 - Boyd; Robert ; et al. | 2014-03-27 |
Novel Compositions for Preventing and/or Treating Degenerative Disorders of the Central Nervous System
App 20140080871 - Boyd; Robert ; et al. | 2014-03-20 |
New Method For Preparing Isofagomine And Its Derivatives
App 20140005372 - Rybczynski; Philip ; et al. | 2014-01-02 |
Compositions for preventing and/or treating lysosomal storage disorders
Grant 8,604,057 - Boyd , et al. December 10, 2 | 2013-12-10 |
Compositions for preventing and/or treating degenerative disorders of the central nervous system
Grant 8,604,206 - Boyd , et al. December 10, 2 | 2013-12-10 |
Method to predict response to pharmacological chaperone treatment of diseases
Grant 8,592,362 - Benjamin , et al. November 26, 2 | 2013-11-26 |
| 